Home › Steatotic Liver Disease › Texas › Houston

Pag-aaral pangklinika para sa Steatotic Liver Disease sa Houston, TX

Isang pag-aaral para sa Steatotic Liver Disease ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Nagre-recruitPhase 3

89bio Clinical Study Site, Houston
89bio Clinical Study Site, Houston
89bio Clinical Study Site, Houston

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Nagre-recruitPhase 3

89bio Clinical Study Site, Houston
89bio Clinical Study Site, Houston
89bio Clinical Study Site, Houston
at 1 pa

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06318169

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Nagre-recruitPhase 3

GSK Investigational Site, Houston
GSK Investigational Site, Bellaire · 7 mi ang layo
GSK Investigational Site, Humble · 17 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Nagre-recruitPhase 3

GSK Investigational Site, Bellaire · 7 mi ang layo
GSK Investigational Site, Humble · 17 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07701993

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Nagre-recruitPhase 2

Pioneer Research Solutions, Inc., Houston

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Nagre-recruitPhase 3

HRI- Medical Center, Houston
Care Access - Houston, Houston
Houston Research Institute, Houston
at 3 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Nagre-recruitPhase 3

Akero Clinical Study Site, Houston
Akero Clinical Study Site, Houston
Akero Clinical Study Site, Houston
at 3 pa

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06528314

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Nagre-recruitPhase 2

Houston Research Institute - Medical Center, Houston
Houston Research Institute, Houston
Bellaire Clinical Research, Bellaire · 7 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07288138

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Nagre-recruitPhase 3

GSK Investigational Site, Houston
GSK Investigational Site, Bellaire · 7 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Nagre-recruitPhase 2

GSK Investigational Site, Houston
GSK Investigational Site, Houston
GSK Investigational Site, Houston

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 8, 2026 · NCT06920043

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo

Pioneer Research Solutions, Houston

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT05648214

NAFLD Clinical Care Pathway

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 14, 2025 · NCT06671886

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Nagre-recruitObservasyonal na pag-aaral

First Surgical Hospital, Bellaire · 7 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 14, 2025 · NCT07122700

Pag-aaral para sa Steatotic Liver Disease sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.